Increase in Principal Amount. Effective as of April 30, 2026, the outstanding principal amount of the Note is increased by $110,000. Accordingly, the total principal amount of the Note shall be $510,000, plus any accrued and unpaid interest. All interest shall continue to accrue in accordance with the terms of the Note.
Appears in 1 contract
Increase in Principal Amount. Effective as of April 30, 2026the Effective Date, the outstanding principal amount of the Note is increased by $110,000. Accordingly, the total principal amount Outstanding Principal Amount of the Note shall be increased by $510,000, plus any accrued and unpaid interest. All interest shall continue to accrue in accordance with 1,492,844 (the terms “March 2024 Principal Increase Amount”) such that the Outstanding Principal Amount as of the NoteEffective Date (after giving effect to any amounts repaid under the Note on the Effective Date) shall be $13,435,599.
Appears in 1 contract
Sources: Convertible Promissory Note (Seelos Therapeutics, Inc.)
Increase in Principal Amount. Effective as of April 30, 2026the Effective Date, the outstanding principal amount of the Note is increased by $110,000. Accordingly, the total principal amount Outstanding Principal Amount of the Note shall be increased by $510,0003,631,528, plus any accrued and unpaid interest. All interest shall continue to accrue in accordance with such that the terms Outstanding Principal Amount as of the NoteEffective Date (after giving effect to any amounts repaid under the Note on the Effective Date) shall be $16,837,084.
Appears in 1 contract
Sources: Convertible Promissory Note and Amendment to Letter Agreement (Seelos Therapeutics, Inc.)